Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference
Envista (NYSE: NVST) will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Envista (NYSE: NVST) will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 from 3:45–4:25 pm PST. A live audio webcast will be available in the Investors section of Envista's website and a replay will be posted for 30 days following the presentation.
Details
News Market Reaction – NVST
On Jan 8, the first trading day after this news, NVST closed 3.01% above the previous close.
Data tracked by StockTitan Argus for the Jan 8 session.
Key Figures
- Conference edition
- 44th annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 12, 2026
- Envista conference presentation
- Presentation time
- 3:45–4:25 pm PST
- Envista session window
- Webcast replay window
- 30 days
- Replay availability on Envista website
Historical Context
-
Announcement of participation in Evercore healthcare conference with webcast access.
-
Strong Q3 2025 adjusted growth but GAAP net loss from tax charge.
-
Release of 2024 sustainability report with ESG progress highlights.
-
Scheduling details for Q3 2025 earnings conference call and webcast.
-
Strong Q2 2025 sales, margin expansion, EPS growth, and guidance raise.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the event will be available in the Investors section of the Envista website at https://investors.envistaco.com/. Additionally, a replay of the webcast will be available on the Envista website for 30 days following the presentation.
ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care—today and for the future. Learn more at http://envistaco.com.
FOR FURTHER INFORMATION
Jim Gustafson
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Telephone: (714) 817-7000
ir@envistaco.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/envista-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302655645.html
SOURCE Envista Holdings Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.